Literature DB >> 19949427

Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients.

Jiguang Guo, Zhongwu Sun, Shifu Xiao, Dongping Liu, Guohua Jin, Ersong Wang, Jiangning Zhou, Jiawei Zhou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19949427     DOI： 10.1038/cr.2009.131

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  12 in total

Review 1.  Proteomic studies on the development of the central nervous system and beyond.

Authors:  Chenggang Zhang
Journal:  Neurochem Res       Date:  2010-06-25       Impact factor: 3.996

Review 2.  Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.

Authors:  Anubhuti Dixit; Rachna Mehta; Abhishek Kumar Singh
Journal:  Cell Mol Neurobiol       Date:  2019-06-12       Impact factor: 5.046

3.  Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy.

Authors:  Yu Wang; Aneeka M Hancock; Joshua Bradner; Kathryn A Chung; Joseph F Quinn; Elaine R Peskind; Douglas Galasko; Joseph Jankovic; Cyrus P Zabetian; Hojoong M Kim; James B Leverenz; Thomas J Montine; Carmen Ginghina; Karen L Edwards; Katherine W Snapinn; David S Goldstein; Min Shi; Jing Zhang
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

4.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Terence Wu; Douglas G Walker; Tyler A Kokjohn; Alex E Roher
Journal:  Neurol Res       Date:  2012-09       Impact factor: 2.448

5.  Specific changes of serum proteins in Parkinson's disease patients.

Authors:  Wenwen Lu; Xinhua Wan; Bin Liu; Xianfang Rong; Lei Zhu; Pingping Li; Jiang Li; Ling Wang; Liying Cui; Xiaoliang Wang
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

Review 6.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

7.  Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary Study.

Authors:  Ashish Kumar Gupta; Komal Rani; Surabhi Swarnkar; Gaurav Khunger Kumar; Mohd Imran Khan; Ruchika Pokhriyal; Domada Ratna Kumar; Vinay Goyal; Manjari Tripathi; Rishab Gupta; Rakesh Kumar Chadda; Perumal Vanamail; Gururao Hariprasad
Journal:  J Cent Nerv Syst Dis       Date:  2018-10-09

Review 8.  Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.

Authors:  Karin D van Dijk; Charlotte E Teunissen; Benjamin Drukarch; Connie R Jimenez; Henk J Groenewegen; Henk W Berendse; Wilma D J van de Berg
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

9.  Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.

Authors:  K Minta; G Brinkmalm; S Janelidze; S Sjödin; E Portelius; E Stomrud; H Zetterberg; K Blennow; O Hansson; U Andreasson
Journal:  Alzheimers Res Ther       Date:  2020-02-13       Impact factor: 6.982

10.  Cerebrospinal fluid proteomics implicates the granin family in Parkinson's disease.

Authors:  Melissa S Rotunno; Monica Lane; Wenfei Zhang; Pavlina Wolf; Petra Oliva; Catherine Viel; Anne-Marie Wills; Roy N Alcalay; Clemens R Scherzer; Lamya S Shihabuddin; Kate Zhang; S Pablo Sardi
Journal:  Sci Rep       Date:  2020-02-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.